NASDAQ: KYMR - Kymera Therapeutics, Inc.

六个月盈利: +37.73%
部门: Healthcare

促销时间表 Kymera Therapeutics, Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司

Kymera Therapeutics, Inc., биофармацевтическая компания, фокусируется на открытии и разработке новых терапевтических средств на малых молекулах, которые избирательно разрушают вызывающие заболевание белки, используя собственную естественную систему расщепления белков организма.

更多详情
Он участвует в разработке программы IRAK4 для лечения иммунологических воспалительных заболеваний, включая гнойный гидраденит, атопический дерматит и ревматоидный артрит; Программа IRAKIMiD для лечения диффузной крупноклеточной В-клеточной лимфомы с мутацией MYD88; и программа STAT3 для лечения гематологических злокачественных новообразований и солидных опухолей, а также аутоиммунных заболеваний. Компания была основана в 2015 году, ее штаб-квартира находится в Уотертауне, штат Массачусетс.

添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

P/S 37.72
P/BV 4.52
EV/EBITDA 1.36
EBITDA -0.0404
Цена ао 48.37
Сайт http://www.kymeratx.com
Число акций ао 0.05837 млрд
P/E 71.85
Выручка 0.0029
Див.доход ао 0
ISIN US5015751044
Валюта usd
IPO date 2020-08-21
Sector Health Care
Industry Biotechnology
Валюта отчета usd
每日价格变化: +0.5195% (48.12)
每周价格变化: +12.38% (43.04)
每月价格变化: +4.97% (46.08)
3个月内价格变化: -0.2475% (48.49)
六个月内的价格变化: +37.73% (35.12)
每年价格变化: +302.75% (12.01)
3年内价格变化: -23.47% (63.2)
年初以来价格变化: +131.55% (20.89)
所有参数

低估

姓名 意义 年级
P/S 19.93 1
P/BV 3.97 4
P/E 71.85 1
EV/EBITDA -10.76 0
全部的: 3.75

效率

姓名 意义 年级
ROA, % -25.52 0
ROE, % -37.21 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.5913 10
全部的: 8

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 2610.07 10
盈利能力 Ebitda, % 254.46 10
盈利能力 EPS, % 89.32 9
全部的: 7.8
更多详情

交易日期 披露日期 内幕 类型 价格 体积 数量 分享最多, % 之后分享, % 文档
26.08.2024 26.08.2024 JEFFREY ALBERS
Director		 购买 47.78 238 900 5000 0 0.01 关联
09.07.2024 09.07.2024 Booth Bruce
Director		 销售 38.21 17 345 800 453960 0 -0.88 关联
23.05.2024 23.05.2024 Chadwick Jeremy G
Chief Operating Officer		 销售 34.99 90 099 2575 0 -0.01 关联
15.03.2024 15.03.2024 Booth Bruce
Director		 销售 40.46 2 903 570 71764 0 -0.14 关联
14.03.2024 15.03.2024 Booth Bruce
Director		 销售 39.98 2 230 040 55779 0 -0.11 关联
13.03.2024 13.03.2024 Booth Bruce
Director		 销售 42.23 5 880 740 139255 0 -0.27 关联
13.03.2024 13.03.2024 Atlas Venture Fund X, L.P.
10% Owner		 销售 42.23 1 020 490 24165 0 -0.05 关联
13.03.2024 13.03.2024 Atlas Venture Fund X, L.P.
10% Owner		 销售 42.23 4 860 250 115090 0 -0.22 关联
12.03.2024 13.03.2024 Booth Bruce
Director		 销售 41.98 6 839 300 162918 0 -0.32 关联
11.03.2024 13.03.2024 Booth Bruce
Director		 销售 42.85 2 193 230 51184 0 -0.1 关联
04.03.2024 04.03.2024 Jacobs Bruce N.
Chief Financial Officer		 销售 41.86 164 677 3934 0 -0.01 关联
08.12.2022 08.12.2022 Mainolfi Nello
Chief Executive Officer		 购买 2.08 20 800 10000 0 0.02 关联
01.11.2022 01.11.2022 Atlas Venture Fund X, L.P.
10% Owner		 销售 30.6 515 549 16848 0 -0.03 关联
01.11.2022 01.11.2022 Atlas Venture Fund X, L.P.
10% Owner		 销售 30.6 1 841 570 60182 0 -0.12 关联
01.11.2022 01.11.2022 Booth Bruce
Director		 销售 30.6 2 357 120 77030 0 -0.15 关联
31.10.2022 01.11.2022 Atlas Venture Fund X, L.P.
10% Owner		 销售 30.23 797 558 26383 0 -0.05 关联
31.10.2022 01.11.2022 Atlas Venture Fund X, L.P.
10% Owner		 销售 30.23 2 848 840 94239 0 -0.18 关联
31.10.2022 01.11.2022 Booth Bruce
Director		 销售 30.23 3 646 400 120622 0 -0.23 关联
28.10.2022 01.11.2022 Atlas Venture Fund X, L.P.
10% Owner		 销售 30 597 450 19915 0 -0.04 关联
28.10.2022 01.11.2022 Atlas Venture Fund X, L.P.
10% Owner		 销售 30 2 134 050 71135 0 -0.14 关联
28.10.2022 01.11.2022 Booth Bruce
Director		 销售 30 2 731 500 91050 0 -0.18 关联
17.10.2022 17.10.2022 Mainolfi Nello
Chief Executive Officer		 购买 2.08 124 243 59732 0 0.12 关联
17.10.2022 17.10.2022 Jacobs Bruce N.
Chief Financial Officer		 购买 2.08 20 800 10000 0 0.02 关联
27.05.2022 31.05.2022 BVF PARTNERS L P/IL
Director		 购买 14.78 966 154 65369 0 0.13 关联
26.05.2022 31.05.2022 BVF PARTNERS L P/IL
Director		 购买 14.21 3 183 850 224057 0 0.44 关联
06.05.2022 09.05.2022 BVF PARTNERS L P/IL
Director		 购买 19.25 1 925 000 100000 0 0.19 关联
05.05.2022 09.05.2022 BVF PARTNERS L P/IL
Director		 购买 19.6 2 940 000 150000 0 0.29 关联
31.01.2022 31.01.2022 BVF PARTNERS L P/IL
Director		 购买 40.7 1 400 410 34408 0 0.08 关联
27.01.2022 31.01.2022 BVF PARTNERS L P/IL
Director		 购买 38.33 3 675 880 95901 0 0.21 关联
12.01.2022 12.01.2022 Mainolfi Nello
Chief Executive Officer		 销售 52.08 448 513 8612 0 -0.02 关联
12.01.2022 12.01.2022 Mainolfi Nello
Chief Executive Officer		 购买 2.08 17 913 8612 0 0.02 关联
11.01.2022 12.01.2022 Mainolfi Nello
Chief Executive Officer		 销售 54 913 842 16923 0 -0.04 关联
11.01.2022 12.01.2022 Mainolfi Nello
Chief Executive Officer		 购买 2.08 35 200 16923 0 0.04 关联
10.01.2022 12.01.2022 Mainolfi Nello
Chief Executive Officer		 销售 53.26 1 196 490 22465 0 -0.05 关联
10.01.2022 12.01.2022 Mainolfi Nello
Chief Executive Officer		 购买 2.08 46 727 22465 0 0.05 关联

机构 体积 分享, %
Baker Brothers Advisors, LLC 5995928 9.81
Atlas Venture Life Science Advisors, LLC 5858262 9.59
Price (T.Rowe) Associates Inc 5335712 8.73
BVF Inc. 5161801 8.45
Wellington Management Group, LLP 4815558 7.88
Vanguard Group Inc 3997564 6.54
Avoro Capital Advisors LLC 3775000 6.18
Blackrock Inc. 3566611 5.84
Artal Group S.A. 2530735 4.14
State Street Corporation 1894279 3.1

ETF 分享, % 本年盈利能力, % 股息, %
Avantis U.S. Equity ETF 0.00593 32.224830464267 1.59151
Virtus LifeSci Biotech Clinical Trials ETF 1.12948 63.040315712071 0.33
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.13795 24.74842126706 1.59225
ProShares Ultra Nasdaq Biotechnology 0.18932 51.697637072723 0.85651
Range Cancer Therapeutics ETF 1.60766 47.24446537918 0.11955
Dimensional U.S. Core Equity 2 ETF 0.01615 30.755198832543 1.47098
Dimensional US Core Equity Market ETF 0.00652 30.983243755928 1.40618
Dimensional U.S. Equity ETF 0.00388 31.530984204131 1.3557
Vanguard ESG U.S. Stock ETF 0 32.395678092399 1.26927
iShares ESG Aware MSCI USA Small-Cap ETF 0.05836 33.616398243045 1.49366
First Trust Multi Cap Growth AlphaDEX Fund 0.11473 41.560262822399 1.02425
Fidelity MSCI Health Care Index ETF 0.0247 13.390080209527 1.46057
First Trust US Equity Opportunities ETF 0.27987 46.431426287541 0.69524
First Trust Nasdaq Pharmaceuticals ETF 0.53997 18.366517675742 2.19901
First Trust Small Cap Growth AlphaDEX Fund 0.55612 42.49956240154 1.22182
First Trust Small Cap Core AlphaDEX Fund 0.18765 34.000896106576 1.87983
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.02965 31.359936575053 1.41955
Harbor Human Capital Factor US Small Cap ETF 1.47381 28.88855891306 0.44
ProShares Hedge Replication ETF 0.01264 5.9237999659878 1.47892
Humankind US Stock ETF 0.01213 18.809430395549 1.99919
Invesco Nasdaq Biotechnology ETF 0.29039 28.578975171685 0.8565
iShares Morningstar Small-Cap ETF 0.04667 30.095066471445 1.60498
iShares Morningstar Small-Cap Growth ETF 0.09127 33.628071953382 0.72598
iShares Russell 2000 Growth ETF 0.16374 38.042556988 0.6026
iShares Russell 3000 ETF 0.00436 32.57283798366 1.43482
iShares Morningstar Small-Cap ETF 0.04667 391.25300933451 1.60498
iShares Morningstar Small-Cap Growth ETF 0.09127 680.05582339508 0.72598
Direxion Daily S&P Biotech Bull 3x Shares 0.3554 4067.9190751445 0.25924
First Trust Multi-Manager Small Cap Opportunities ETF 0.46375 48.514285714286 0.31756
Nuveen ESG Small-Cap ETF 0.09707 29.971671388102 1.41019
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.01727 35.452103849597 1.75869
Schwab U.S. Small-Cap ETF 0.0572 34.281650071124 1.51433
Schwab U.S. Broad Market ETF 0.00398 32.5 1.43354
SPDR Portfolio MSCI Global Stock Market ETF 0.00611 23.600605143722 2.19607
FlexShares Morningstar US Market Factor Tilt Index Fund 0.00831 32.205226109465 1.69572
ProShares UltraPro Russell2000 0.04783 89.821266282945 1.47873
Vanguard Russell 3000 ETF 0 31.87314172448 1.43817
Vanguard Russell 2000 Growth ETF 0.16 39.350070246167 0.60264
Vanguard Russell 2000 ETF 0.08 35.648084105685 1.48801
Principal Healthcare Innovators ETF 0.31198 618.4964157054 0.8416
Future Tech ETF 0.31198 426.33969118983 0.8416



导师 职称 支付 出生年份
Dr. Nello Mainolfi M.D., Ph.D. Co-Founder, President, CEO & Director 975.2k 1979 (45 年)
Mr. Bruce N. Jacobs CFA Chief Financial Officer 648.3k
Dr. Jared A. Gollob M.D. Chief Medical Officer 637.81k 1965 (59 年)
Ms. Ellen V. Chiniara Esq., J.D. Chief Legal Officer & Corporate Secretary N/A 1959 (65 年)
Dr. Jeremy G. Chadwick Ph.D. Chief Operating Officer N/A 1963 (61 年)
Ms. Karen Weisbach Head of People & Culture N/A
Dr. Bruce L. Booth DPHIL, Ph.D. Co-Founder & Independent Chairman 79.19k 1974 (50 年)
Dr. Juliet Williams B.A Ph.D. Head of Research N/A

地址: United States, Watertown, MA , 200 Arsenal Yards Boulevard - 在 Google 地图中打开, 打开 Yandex 地图
网站: http://www.kymeratx.com